We advised Altavion Oy on the sale of Albiox Oy to Indutrade AB
We advised Altavion Oy on the sale of Albiox Oy to Indutrade AB
August 06, 2026
Finland
Finland
Finland
Eversheds acted as advisor to Altavion Oy in the sale of its subsidiary Albiox Oy to Indutrade AB (Nasdaq Stockholm: INDT), a Swedish serial acquirer of technology and industrial businesses.
Albiox Oy supplies products, equipment and tailored value-added services to the pharmaceutical, research and diagnostics sectors, with a product range covering syringes, needles, packaging solutions and specialty reagents for demanding sterile cleanroom work. The company is a strong addition to Indutrade's Life Science business area, complementing the Finnish company Labema Oy, which Indutrade acquired in June 2023.
Our team supported Altavion's shareholders throughout the process, from approaching prospective buyers on behalf of the company through to due diligence and negotiation of the transaction documentation.
Our work covered both financial and legal advisory services, including buyer contact and competitive process management, maintaining the data room, assisting with the seller's financial and legal due diligence, drafting the completion-related documentation, and negotiating the share purchase agreement and its schedules. The matter was handled by Henri Steiner, Olli Iirola and Sanni Tirkkonen on the legal advisory side, together with Henri Falck and Amos Iirola on the financial advisory side.
The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer. Eversheds Sutherland is a provider of legal and other services operating through various separate and distinct legal entities. For further information about these entities and Eversheds Sutherlands' structure please see the Legal Notice page of this website.